Whole Network Most Recent TOP10 Gene Therapy Microbiology Nanomedicine Stem Cells


Shewanella oneidensis MR-1 Bacteria Protects Metals Against Corrosion Title: Shewanella oneidensis MR-1 Bacteria Protects Metals Against Corrosion
PermaLink: http://www.biotech-weblog.com/50226711/shewanella_oneidensis_mr1_bacteria_protects_metals_against_corrosion.php

Filed in archive Microbiology by ruth on June 19, 2006

Researchers have demonstrated the protective ability of a bacteria, Shewanella oneidensis MR-1, to protect metals from corrosion. In a simple laboratory experiment where MR-1 was allowed to form...

Read the full post.

Advertisement - Book yours here.



RNAi and Antisense RNA Therapy from the Tangled Bank Title: RNAi and Antisense RNA Therapy from the Tangled Bank
PermaLink: http://www.biotech-weblog.com/50226711/rnai_and_antisense_rna_therapy_from_the_tangled_bank.php

Filed in archive Biotech/Science Blogs , Drugs, Vaccines and Therapeutics , Genomics, Proteomics and Bioinformatics by ruth on June 19, 2006

The 54th issue of Tangled Bank, a carnival of science blogs, is up and it's hosted at Daniel Morgan's. I picked up two entries which may be of interest to readers of this blog, and both can...

Read the full post.



Pine Tree Extract Pycnogenol® Reduces ADHD Symptoms Title: Pine Tree Extract Pycnogenol® Reduces ADHD Symptoms
PermaLink: http://www.biotech-weblog.com/50226711/pine_tree_extract_pycnogenola_reduces_adhd_symptoms.php

Filed in archive Drugs, Vaccines and Therapeutics , Food and Agriculture by ruth on June 19, 2006

Extracts form the bark of the French maritime pine tree (commercially available as Pycnogenol®), may reduce the symptoms of Attention-Deficit/Hyperactivity Disorder (ADHD), a neurobehavioral...

Read the full post.



5th BioBusiness Asia Conference Title: 5th BioBusiness Asia Conference
PermaLink: http://www.biotech-weblog.com/50226711/5th_biobusiness_asia_conference.php

Filed in archive Meetings and Other Events by ruth on June 16, 2006

What: 5th BioBusiness Asia (BBA) Conference When: July 25-26, 2006 Where: Grand Hyatt Hotel, Taipei, Taiwan Join emerging biotech companies in the Asia pacific region discuss global trends, business...

Read the full post.



Bayer Takes Over Schering Title: Bayer Takes Over Schering
PermaLink: http://www.biotech-weblog.com/50226711/bayer_takes_over_schering.php

Filed in archive Corporate and Industrial News by ruth on June 16, 2006

It seems that after a minor hiccup, Bayer does take over Schering after reaching a settlement with Merck. Bayer AG is to acquire the entire 21,8% stake in Schering shares held by Merck. The purchase...

Read the full post.



ACtivating Sonic Hedgehog Signals Triggers Growth of New Blood Vessels in the Heart Title: ACtivating Sonic Hedgehog Signals Triggers Growth of New Blood Vessels in the Heart
PermaLink: http://www.biotech-weblog.com/50226711/activating_sonic_hedgehog_signals_triggers_growth_of_new_blood_vessels_in_the_heart.php

Filed in archive Drugs, Vaccines and Therapeutics , Genomics, Proteomics and Bioinformatics by ruth on June 16, 2006

In attempt to bypass damaged tissues and clogged arteries in patients with Coronary artery disease, scientists have tried to prompt the heart to develop new blood vessels by stimulating blood-vessel...

Read the full post.



Novel Peptide for Imaging and Drug Delivery Tool for Lymphoid Cancers Title: Novel Peptide for Imaging and Drug Delivery Tool for Lymphoid Cancers
PermaLink: http://www.biotech-weblog.com/50226711/novel_peptide_for_imaging_and_drug_delivery_tool_for_lymphoid_cancers.php

Filed in archive Diagnostics, Methodologies and Instrumentation , Drugs, Vaccines and Therapeutics by ruth on June 15, 2006

Scientists have developed a peptide that, like monoclonal antibodies, can bind to the surface of leukemia and lymphoma cells. Unlike monoclonal antibodies, however, they are (1) smaller, and can...

Read the full post.



Novartis Buys Rights to Intecell's Japanese Encephalitis Vaccine Candidate Title: Novartis Buys Rights to Intecell's Japanese Encephalitis Vaccine Candidate
PermaLink: http://www.biotech-weblog.com/50226711/novartis_buys_rights_to_intecells_japanese_encephalitis_vaccine_candidate.php

Filed in archive Corporate and Industrial News , Drugs, Vaccines and Therapeutics by ruth on June 14, 2006

Novartis is buying rights to Austrian biotech firm Intercell AG's IC51 experimental vaccine against the tropical disease Japanese encephalitis. IC51 will be an addition to Novartis' portfolio...

Read the full post.



UCSF Recruits Smokers For NicVax Trials Title: UCSF Recruits Smokers For NicVax Trials
PermaLink: http://www.biotech-weblog.com/50226711/ucsf_recruits_smokers_for_nicvax_trials.php

Filed in archive Drugs, Vaccines and Therapeutics by ruth on June 13, 2006

Earlier this year, Nabi Pharmaceuticals' NicVax received a fast-track designation by the Food and Drug Administration to speed up the development of the investigational vaccine against nicotine...

Read the full post.



Merck Ups Stake in Schering, Threatening Bayer's Takeover Title: Merck Ups Stake in Schering, Threatening Bayer's Takeover
PermaLink: http://www.biotech-weblog.com/50226711/merck_ups_stake_in_schering_threatening_bayers_takeover.php

Filed in archive Corporate and Industrial News by ruth on June 13, 2006

It seems that the $20 billion merger between German biopharmaceutical giants Bayer and Schering may not take place afterall. Read the news from Forbes, from Reuters and from AP (via Canada.com): Merck...

Read the full post.



Bone Marrow Stem Cells May Repair Retinal Damage Title: Bone Marrow Stem Cells May Repair Retinal Damage
PermaLink: http://www.biotech-weblog.com/50226711/bone_marrow_stem_cells_may_repair_retinal_damage.php

Filed in archive Stem Cells by ruth on June 12, 2006

It is widely believed among scientists that like brain cells, the retinal pigment epithelium (RPE), a cell layer that plays a vital role in eyesight is a nonrenewable resource. In diseases of the...

Read the full post.



FDA Approves Gardasil Cervical Cancer Vaccine Title: FDA Approves Gardasil Cervical Cancer Vaccine
PermaLink: http://www.biotech-weblog.com/50226711/fda_approves_gardasil_cervical_cancer_vaccine.php

Filed in archive Drugs, Vaccines and Therapeutics by ruth on June 12, 2006

Following a favorable review by the FDA Advisory Panel, the US FDA has finally approved Gardasil, the world's first and only cervical cancer vaccine. The recombinant vaccine has been demonstrated...

Read the full post.



Industry Roundtable: "Financing & Funding Options" Tips from Top Financiers Title: Industry Roundtable: "Financing & Funding Options" Tips from Top Financiers
PermaLink: http://www.biotech-weblog.com/50226711/industry_roundtable_financing_funding_options_tips_from_top_financiers.php

Filed in archive Meetings and Other Events by ruth on June 11, 2006

What: Industry Roundtable: "Financing & Funding Options" Tips from Top Financiers When: June 22, 2006 Where: San Jose BioCenter, California Agenda: 3:00-3:30 PM Networking &...

Read the full post.



Origen To Produce Therapeutics in Genetically Engineered Chickens Title: Origen To Produce Therapeutics in Genetically Engineered Chickens
PermaLink: http://www.biotech-weblog.com/50226711/origen_to_produce_therapeutics_in_genetically_engineered_chickens.php

Filed in archive Diagnostics, Methodologies and Instrumentation , Drugs, Vaccines and Therapeutics , Food and Agriculture , Genomics, Proteomics and Bioinformatics , Stem Cells by ruth on June 09, 2006

Spurred by European regulators' approval of the production of an anti-clotting agent in transgenic goats, other firms are tailgating. California-based Origen Therapeutics have been developing...

Read the full post.



EU Approves Humira® Drug Against Ankylosing Spondylitis Title: EU Approves Humira® Drug Against Ankylosing Spondylitis
PermaLink: http://www.biotech-weblog.com/50226711/eu_approves_humiraa_drug_against_ankylosing_spondylitis.php

Filed in archive Drugs, Vaccines and Therapeutics by ruth on June 08, 2006

EU regulatory bodies granted approval to market Humira® (adalimumab) in Europe. Humira is an arthritis drug from Abbott, indicated for severe, active ankylosing spondylitis (AS). Ankylosing...

Read the full post.



Novartis Bids for NeuTec, Expands Into Hospital Anti-Infectives Title: Novartis Bids for NeuTec, Expands Into Hospital Anti-Infectives
PermaLink: http://www.biotech-weblog.com/50226711/novartis_bids_for_neutec_expands_into_hospital_antiinfectives.php

Filed in archive Corporate and Industrial News , Drugs, Vaccines and Therapeutics by ruth on June 08, 2006

Novartis is hoping to strengthen its biopharmaceutical portfolio by offering to acquire British firm NeuTec Pharma plc for $570 million, a 109% premium to the current share price. NeuTec's...

Read the full post.



EMEA Approves First Therapeutic Produced in Transgenic Goat Title: EMEA Approves First Therapeutic Produced in Transgenic Goat
PermaLink: http://www.biotech-weblog.com/50226711/emea_approves_first_therapeutic_produced_in_transgenic_goat.php

Filed in archive Drugs, Vaccines and Therapeutics , Food and Agriculture , Genomics, Proteomics and Bioinformatics by ruth on June 07, 2006

Following a re-examination, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has recommended approval for GTC Biotherapeutics' ATryn, a...

Read the full post.



Nastech To Start Human Clinical Trials on Intranasal Obesity Spray Title: Nastech To Start Human Clinical Trials on Intranasal Obesity Spray
PermaLink: http://www.biotech-weblog.com/50226711/nastech_to_start_human_clinical_trials_on_intranasal_obesity_spray.php

Filed in archive Corporate and Industrial News , Drugs, Vaccines and Therapeutics by ruth on June 07, 2006

Nastech Pharmaceutical Company Inc. filed an Investigational New Drug (IND) application to the U.S. FDA for the PYY3-36 (PYY) nasal spray against obesity, and upon approval, hopes to then initiate...

Read the full post.



FDA Approves New Hyaluronic Acid Formulation As Dermal Fillers For Facial Wrinkles Title: FDA Approves New Hyaluronic Acid Formulation As Dermal Fillers For Facial Wrinkles
PermaLink: http://www.biotech-weblog.com/50226711/fda_approves_new_hyaluronic_acid_formulation_as_dermal_fillers_for_facial_wrinkles.php

Filed in archive Drugs, Vaccines and Therapeutics , Microbiology by ruth on June 07, 2006

From the makers of Botox comes another line of dermal fillers for the treatment of facial wrinkles and folds. The Juvederm gel family of products is composed of highly concentrated cross-linked...

Read the full post.



CW ToolbarInstall
RSSrss   | See all blog subscribe options
Googlegoogle   |   What is RSS?
Yahoo!yahoo
AddthisAddThis Feed Button
BloglinesBloglines
Newsletter
Advertisement - Book yours here.

Use our search feature to look for other interesting posts

Just this blog Whole network
Advertisement -
Book yours here..


 
Advertisement
Book yours here.



  • Testimonials

  • 'Very nice blog layout with great content. Are you interested in Star Trek props that are quickly becoming reality? Then this is the blog for you. Human medical scanners, nano technology and more great technological advancements.' -VirtualLoop Blog of the Week

    'I subscribe to your blog and have been enjoying your posts and perspective.'
  • Other blogs in the same channel in the Creative Weblogging Network

Advertisement -
Book yours here..






Advertisement - Book yours here..
 
Tagcloud: Biotech Hubs and Facilities Biotech/Science Blogs Corporate and Industrial News Diagnostics, Methodologies and Instrumentation Drugs, Vaccines and Therapeutics Energy, Environment and Ecology Food and Agriculture Gene Therapy Genomics, Proteomics and Bioinformatics Meetings and Other Events Microbiology Nanomedicine Other Biotechnology News Patents and Intellectual Property Rights Sponsored Post Stem Cells